(Q36967155)

17 August 2017

1 reference

title

Modern management of small-cell lung cancer (English)

1 reference

17 August 2017

1 reference

6

1 reference

17 August 2017

Corinne Faivre-Finn

4

0 references

author name string

Roberta Ferraldeschi

1

1 reference

17 August 2017

Sofia Baka

2

1 reference

17 August 2017

Babita Jyoti

3

1 reference

17 August 2017

Nick Thatcher

5

1 reference

17 August 2017

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

67

1 reference

17 August 2017

issue

15

1 reference

17 August 2017

page(s)

2135-2152

1 reference

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767150-00003

A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767150-00003

Radiation dose escalation in limited-stage small-cell lung cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767150-00003

Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer

21 January 2018

1 reference

12 December 2020

Synergistic interactions of combinations of topotecan with standard drugs in primary cultures of human tumor cells from patients

1 reference

12 December 2020

Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism?

1 reference

12 December 2020

Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer

1 reference

12 December 2020

Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial

1 reference

12 December 2020

Small-cell carcinoma of the lung: derivation of a prognostic staging system

1 reference

12 December 2020

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

1 reference

12 December 2020

Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation

1 reference

12 December 2020

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European

1 reference

12 December 2020

Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?

1 reference

12 December 2020

Full chemotherapy in elderly patients with small cell bronchial carcinoma

1 reference

12 December 2020

Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up

1 reference

12 December 2020

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial

1 reference

12 December 2020

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis

1 reference

12 December 2020

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

1 reference

12 December 2020

Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer

1 reference

12 December 2020

Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.

1 reference

12 December 2020

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea

1 reference

12 December 2020

Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update

1 reference

12 December 2020

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America

1 reference

12 December 2020

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

12 December 2020

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

12 December 2020

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

1 reference

12 December 2020

Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083

1 reference

12 December 2020

Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01

1 reference

12 December 2020

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

1 reference

12 December 2020

Comorbidity and functional status are independent in older cancer patients

1 reference

12 December 2020

Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial

1 reference

12 December 2020

Influence of age on the treatment of limited-stage small-cell lung cancer

1 reference

12 December 2020

The Value of Anatomic Staging and Other Prognostic Factors in Small Cell Lung Cancer Management: A View of European Studies

1 reference

12 December 2020

Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lung

1 reference

12 December 2020

New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen

1 reference

12 December 2020

Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials

1 reference

12 December 2020

Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer. Rationale for current approach

1 reference

12 December 2020

Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung

1 reference

12 December 2020

Surgical resection in the management of small cell carcinoma of the lung

1 reference

12 December 2020

Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.

1 reference

12 December 2020

Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin

1 reference

12 December 2020

Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.

1 reference

12 December 2020

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

1 reference

12 December 2020

Age and the treatment of lung cancer

1 reference

12 December 2020

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities

1 reference

12 December 2020

Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer

1 reference

12 December 2020

Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer

1 reference

12 December 2020

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.

1 reference

12 December 2020

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group

1 reference

12 December 2020

First-line chemotherapy rechallenge after relapse in small cell lung cancer

1 reference

12 December 2020

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

1 reference

12 December 2020

Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer

1 reference

12 December 2020

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Synergistic interaction between topotecan and microtubule-interfering agents

1 reference

12 December 2020

Intensive chemotherapy of small cell bronchogenic carcinoma

1 reference

12 December 2020

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

12 December 2020

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer

1 reference

12 December 2020

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

12 December 2020

Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions

1 reference

12 December 2020

Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base

1 reference

12 December 2020

CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

1 reference

12 December 2020

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

1 reference

12 December 2020

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

1 reference

12 December 2020

Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

1 reference

12 December 2020

A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy

1 reference

12 December 2020

A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study

1 reference

12 December 2020

1 reference

12 December 2020

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

12 December 2020

Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.

1 reference

12 December 2020

Treatment of recurrent small cell lung cancer

1 reference

12 December 2020

Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients

1 reference

12 December 2020

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress

1 reference

12 December 2020

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

1 reference

12 December 2020

Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study

1 reference

12 December 2020

The Feasibility of Adjuvant Surgery in Limited-Stage Small Cell Carcinoma: A Prospective Evaluation

1 reference

12 December 2020

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer

1 reference

12 December 2020

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

1 reference

12 December 2020

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

12 December 2020

In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants

1 reference

12 December 2020

A new international staging system for lung cancer

1 reference

12 December 2020

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

12 December 2020

The role of surgery in the management of selected patients with small-cell carcinoma of the lung

1 reference

12 December 2020

Five-year survival in treated stage I and II small cell carcinoma of the lung

1 reference

12 December 2020

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

12 December 2020

Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years

1 reference

12 December 2020

Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer

1 reference

12 December 2020

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study

1 reference

12 December 2020

Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial. The "Petites Cellules" Group

1 reference

12 December 2020

Keynote address on biostatistics and data retrieval.

1 reference

12 December 2020

Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer

1 reference

12 December 2020

Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicent

1 reference

12 December 2020

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

1 reference

12 December 2020

Treatment of small cell lung carcinoma in the elderly

1 reference

12 December 2020

Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer

1 reference

12 December 2020

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

1 reference

12 December 2020

Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group

1 reference

12 December 2020

Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis

1 reference

12 December 2020

Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics

1 reference

12 December 2020

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

1 reference

12 December 2020

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1 reference

12 December 2020

Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer

1 reference

12 December 2020

A research and service oriented multilevel assessment instrument

1 reference

12 December 2020

Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer

1 reference

12 December 2020

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

12 December 2020

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

12 December 2020

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

1 reference

12 December 2020

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research

1 reference

12 December 2020

Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).

1 reference

12 December 2020

A prospective analysis of chemotherapy following surgical resection of clinical stage I-II small-cell lung cancer

1 reference

12 December 2020

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

1 reference

12 December 2020

Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study

1 reference

12 December 2020

Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial

1 reference

12 December 2020

Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report

1 reference

12 December 2020

Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer

1 reference

12 December 2020

Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis

1 reference

12 December 2020

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

12 December 2020

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

12 December 2020

Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis

1 reference

12 December 2020

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

12 December 2020

Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. For the ISC-Lung Cancer Study Group.

1 reference

12 December 2020

Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group

1 reference

12 December 2020

A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group

1 reference

12 December 2020

Small-cell lung cancer in the elderly--is age of patient a relevant factor?

1 reference

12 December 2020

Carboplatin in the Treatment of Small Cell Lung Cancer

1 reference

12 December 2020

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

12 December 2020

Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group

1 reference

12 December 2020

Postchemotherapy resection of residual tumor in limited stage small cell lung cancer

1 reference

12 December 2020

Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study

1 reference

12 December 2020

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

12 December 2020

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

1 reference

12 December 2020

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

12 December 2020

Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer

1 reference

12 December 2020

Maintenance chemotherapy for small cell lung cancer: a critical review of the literature

1 reference

12 December 2020

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study

1 reference

12 December 2020

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

1 reference

12 December 2020

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and

1 reference

12 December 2020

Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer

1 reference

12 December 2020

Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma

1 reference

12 December 2020

10.2165/00003495-200767150-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

1017241620

0 references

1 reference